US FDA flags data integrity, contamination lapses at Dabur's Dadra plant
A January inspection of Dabur India's Dadra and Nagar Haveli facility surfaced falsified records, a live bird in the raw material warehouse, and unreliable microbiology testing for US-exported consumer health products. The findings put Dabur's US export pipeline and quality controls under scrutiny.
US FDA flagged data integrity, contamination and maintenance lapses at Dabur India's Dadra and Nagar Haveli plant after a January inspection, citing falsified records, a live bird in the raw material warehouse, and unreliable microbiology testing for US-exported consumer health products.
Why this matters
FDA findings compound pressure on Dabur, which is already shrinking Rs 10 and Rs 20 packs to defend price points against a 10% input cost surge. US export disruptions would hit a key growth channel.
Retail-company signals steady at 1,382 over the past 90 days.